Recursion Pharmaceuticals RXRX
Last Price
52 Week Range
$3.79 - $12.36
Next Earnings Date
Feb 27 2026 (Estimate)
Next Earnings Date
Feb 27 2026 (Est.)
Last Price
RXRX Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Recursion Pharmaceuticals, Inc. | 8-K | January 12, 2026 | |
Recursion Pharmaceuticals, Inc. | 8-K | December 8, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | November 26, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | November 5, 2025 | |
Recursion Pharmaceuticals, Inc. | 10-Q | November 5, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | October 29, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | August 5, 2025 | |
Recursion Pharmaceuticals, Inc. | 10-Q | August 5, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | July 8, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | June 18, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | June 10, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | May 9, 2025 | |
Recursion Pharmaceuticals, Inc. | 10-Q | May 5, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | May 5, 2025 | |
Recursion Pharmaceuticals, Inc. | DEF 14A | April 28, 2025 | |
Recursion Pharmaceuticals, Inc. | DEFA14A | April 28, 2025 | |
Recursion Pharmaceuticals, Inc. | ARS | April 28, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | March 18, 2025 | |
Recursion Pharmaceuticals, Inc. | 10-K | February 28, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | February 28, 2025 | |
Recursion Pharmaceuticals, Inc. | S3ASR | February 12, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | January 13, 2025 | |
Recursion Pharmaceuticals, Inc. | 8-K | December 17, 2024 | |
Recursion Pharmaceuticals, Inc. | 8-K | December 3, 2024 | |
Recursion Pharmaceuticals, Inc. | 8-K | November 20, 2024 | |
Recursion Pharmaceuticals, Inc. | 8-K | November 13, 2024 | |
Recursion Pharmaceuticals, Inc. | 8-K | November 13, 2024 | |
Recursion Pharmaceuticals, Inc. | DEFA14A | November 6, 2024 | |
Recursion Pharmaceuticals, Inc. | 8-K | November 6, 2024 | |
Recursion Pharmaceuticals, Inc. | 8-K | November 6, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.